Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 726 - 750 of 2,711

«
1
…
28
29
30
31
32
…
109
»

Genitourinary and Gynecologic Malignancies Session

Genitourinary and Gynecologic Malignancies Session

By: Gerardo Colon-Otero, MD, Daniel Petrylak, MD,

Prostate Cancer: Diagnostic and Therapeutic Updates

Prostate Cancer: Diagnostic and Therapeutic Updates

By: Karine Tawagi, MD

GU Cancer Case

By: Mamta Parikh, MD, MS

How I Treat Metastatic Urothelial Cancer when IO Therapy Fails

How I Treat Metastatic Urothelial Cancer when IO Therapy Fails

By: Mamta Parikh, MD, MS

Updates in Genitourinary Cancers

Updates in Genitourinary Cancers

By: Mamta Parikh, MD, MS

Challenging Case #2: Genitourinary Cancer

Challenging Case #2: Genitourinary Cancer

By: Mamta Parikh, MD, MS

GU Cancer and State of the Art: Castration Resistant Prostate Cancer

GU Cancer and State of the Art: Castration Resistant Prostate Cancer

By: Mamta Parikh, MD, MS

Updates in Genitourinary Cancers

Updates in Genitourinary Cancers

By: Mamta Parikh, MD, MS

Renal Cell Cancer: Emerging Standards of Care and Future Directions

Renal Cell Cancer: Emerging Standards of Care and Future Directions

By: Mamta Parikh, MD, MS

Castration Resistant Prostate Cancer: What is the Optimal Strategy?

Castration Resistant Prostate Cancer: What is the Optimal Strategy?

By: Mamta Parikh, MD, MS

Urology Updates from AUA Meeting

Urology Updates from AUA Meeting

By: Michael A. Daneshvar, MD

Renal Cancer Updates

Renal Cancer Updates

By: Nataliya Mar, MD

State of the Art in Genitourinary Cancers

State of the Art in Genitourinary Cancers

By: Nicholas Mitsiades, MD, PhD

State of the Art in Genitourinary Cancers

State of the Art in Genitourinary Cancers

By: Nicholas Mitsiades, MD, PhD

State of the Art in Genitourinary Cancers

State of the Art in Genitourinary Cancers

By: Nicholas Mitsiades, MD, PhD

Panel-Optimal Therapies in Genitourinary Cancers

Panel-Optimal Therapies in Genitourinary Cancers

By: Panel

Optimal Therapies in Genitourinary Cancers

Optimal Therapies in Genitourinary Cancers

By: Panel

Kidney & Bladder Cancer: Targeted, Immuno & Other Strategies

Kidney & Bladder Cancer: Targeted, Immuno & Other Strategies

By: Pedro Barata, MD, MSc

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

By: Petros Grivas, MD, PhD

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

By: Petros Grivas, MD, PhD

Targeted Therapies in Metastatic RCC: Monotherapy Versus Combination Therapy

Targeted Therapies in Metastatic RCC: Monotherapy Versus Combination Therapy

By: Primo N Lara - Jr. - MD

Renal Cell Cancer: Navigating a Maze of Choices

Renal Cell Cancer: Navigating a Maze of Choices

By: Primo N. Lara, Jr. (UCD)

Targeted Therapies in Metastatic RCC Monotherapy versus Combination Therapy

Targeted Therapies in Metastatic RCC Monotherapy versus Combination Therapy

By: Primo N. Lara, Jr., MD

Clinical Applications for Liquid Biopsy in
GU Cancers Update

Clinical Applications for Liquid Biopsy in GU Cancers Update

By: Rafee W. Talukder, MD

State of the Art in Genitourinary Cancers

State of the Art in Genitourinary Cancers

By: RALPH DE VERE WHITE, MD

«
1
…
28
29
30
31
32
…
109
»

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok